We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Mixed Verdict on Generic Mesalamine Citizen Petitions
FDA Gives Mixed Verdict on Generic Mesalamine Citizen Petitions
August 27, 2010
The FDA has partially granted citizen petitions from Shire and Warner Chilcott on how generic-drug makers should prove bioequivalence for generic formulations of extended-release mesalamine, used to treat ulcerative colitis.